Drug Overview

Cabazitaxel is a powerful, next-generation cancer medication specifically designed to fight advanced forms of prostate cancer. While many modern treatments are known as “Targeted Therapies” or “Smart Drugs,” cabazitaxel is a highly advanced form of traditional chemotherapy. It was specially created in a laboratory to keep working even when prostate cancer cells have figured out how to resist older chemotherapy drugs.

When prostate cancer spreads to other parts of the body and stops responding to hormone treatments and initial chemotherapy, cabazitaxel offers an important lifeline to help slow the disease down and extend life.

Generic Name: Cabazitaxel
US Brand Names: Jevtana
Drug Class: Microtubule Inhibitor / Taxane (Antineoplastic Agent)
Route of Administration: Intravenous (IV) Infusion (delivered directly into a vein)
FDA Approval Status: Fully FDA Approved

What Is It and How Does It Work? (Mechanism of Action)

To understand how cabazitaxel works, we have to look inside a cancer cell at its “skeleton.” Cells have an internal support system made of tiny tubes called microtubules. These tubes act like a microscopic highway system that moves parts around inside the cell. When a cell gets ready to divide and multiply, these tubes must rapidly break down and rebuild themselves.

At the molecular level, cabazitaxel binds tightly to a protein called tubulin, which is the building block of these microtubules. By locking onto the tubulin, the drug “freezes” the cell’s skeleton. Because the internal tubes cannot break apart and rebuild, the cancer cell is physically unable to divide into two new cells. This massive internal traffic jam causes the cancer cell to stop growing and eventually die (a process called apoptosis).

Overcoming Resistance: What makes cabazitaxel unique is how it deals with resistant cancer. Cancer cells are smart and often create tiny “pumps” (called P-glycoprotein efflux pumps) on their surface to spit out older chemotherapy drugs before they can work. Cabazitaxel was structurally engineered to be “invisible” to these pumps. It stays inside the cancer cell longer, allowing it to destroy tumors that have become completely resistant to older drugs like docetaxel.

FDA Approved Clinical Indications

Oncological Uses

Treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with a regimen containing docetaxel. (It is approved to be used in combination with a steroid called prednisone).

Non-Oncological Uses

There are no FDA-approved non-oncological uses for this medication. It is prescribed exclusively for cancer.

Dosage and Administration Protocols

Cabazitaxel is given in a hospital or clinic setting by trained healthcare professionals. Because it can cause allergic reactions, patients are given a combination of “pre-medications” (like antihistamines and anti-nausea drugs) at least 30 minutes before the infusion begins.

Patient Group	Standard Dose	Frequency	Administration Notes
Metastatic Prostate Cancer (Standard)	20 mg/m² or 25 mg/m² (based on body surface area)	Once every 3 weeks	Administered as a 1-hour IV infusion. Taken alongside 10 mg of oral prednisone daily.
Patients with Mild Hepatic (Liver) Insufficiency	Reduced Dose: 20 mg/m²	Once every 3 weeks	Liver function must be checked before every dose.
Patients with Moderate to Severe Hepatic Insufficiency	Contraindicated (Do Not Use)	N/A	Because the liver processes this drug, severe liver disease makes it toxic to the body.
Patients with Renal (Kidney) Insufficiency	Standard Dose	Once every 3 weeks	No dose change is needed for mild to moderate kidney disease, but doctors will monitor severe cases closely.

Note: Your doctor will decide whether the 20 mg or 25 mg dose is right for you based on your age, overall health, and history of side effects.

Clinical Efficacy and Research Results

Cabazitaxel has been proven to extend life for men with advanced prostate cancer. Recent clinical analysis (spanning 2020-2025), specifically looking at the landmark CARD clinical trial, confirmed its strong role in modern cancer care.

Survival Rates: In the CARD trial, which looked at men whose prostate cancer had grown despite prior treatments, cabazitaxel significantly improved overall survival. Patients receiving cabazitaxel lived a median of 13.6 months, compared to 11.0 months for those taking alternative hormone therapies.
Effects on Disease Progression: The drug cut the risk of the cancer growing or spreading by nearly half compared to other standard options.
Pain Relief: Numerical data shows that cabazitaxel also helped reduce cancer-related bone pain in a significantly higher percentage of patients, improving their daily quality of life.

Safety Profile and Side Effects

Because cabazitaxel is a strong chemotherapy, it affects both cancer cells and some healthy, fast-growing cells in the body.

BLACK BOX WARNING

The FDA has issued a strict Black Box Warning for Cabazitaxel regarding two life-threatening risks:

Severe Neutropenia: The drug causes a massive drop in neutrophils (a type of white blood cell). This can lead to fatal infections. It must not be given to patients whose neutrophil counts are too low.
Severe Hypersensitivity: The drug can cause extreme, life-threatening allergic reactions. Patients must receive pre-medications and be monitored closely during the IV infusion.

Common Side Effects (>10%)

Anemia: Low red blood cells, causing fatigue and weakness.
Diarrhea: This can be severe and requires immediate attention.
Nausea and Vomiting
Fatigue (Asthenia): Extreme tiredness that does not improve with sleep.
Hematuria: Blood in the urine.
Back and Abdominal Pain

Serious Adverse Events

Febrile Neutropenia: A dangerous combination of a fever and low white blood cells, signaling a severe infection.
Renal Failure: Kidney damage, often caused by severe dehydration from diarrhea.
Gastrointestinal Issues: Rarely, it can cause severe bleeding or holes (perforations) in the intestines.

Management Strategies

For Low White Blood Cells: Doctors routinely prescribe a “growth factor” injection (like G-CSF/pegfilgrastim) a day after the chemotherapy. This forces the bone marrow to rapidly produce new white blood cells to prevent infections.
For Diarrhea: Patients are instructed to keep anti-diarrhea medicines (like loperamide) at home and drink plenty of clear fluids. If diarrhea lasts more than 24 hours, they must contact their doctor to prevent kidney damage from dehydration.

Research Areas

While cabazitaxel is a traditional chemotherapy, it is heavily involved in modern Immunotherapy and targeted radiation research. Prostate cancer is often called a “cold” tumor because the body’s immune system ignores it. Current clinical trials are studying whether breaking apart cancer cells with cabazitaxel can release signals that turn the tumor “hot.” Researchers are testing cabazitaxel in combination with modern immune checkpoint inhibitors (immunotherapy) and targeted radioligand therapies (like Lutetium-177 PSMA) to see if a combination approach can wipe out the cancer entirely and encourage the body to build long-lasting immunity against the disease.

Patient Management and Practical Recommendations

Pre-Treatment Tests to be Performed

Complete Blood Count (CBC): Must be performed before every single infusion to ensure white blood cells are high enough to safely receive the drug.
Comprehensive Metabolic Panel (CMP): To thoroughly check liver enzymes (AST, ALT, Bilirubin) and kidney function.

Precautions During Treatment

Infection Risk: Because your immune system will be temporarily weakened, you must avoid large crowds and people who are sick.
Hydration: You must drink plenty of water every day to protect your kidneys, especially if you experience diarrhea.

“Do’s and Don’ts” List

DO take your prescribed steroids (prednisone) exactly as directed by your doctor.
DO check your temperature at home with a thermometer. Call your doctor immediately or go to the emergency room if you have a fever of 100.4°F (38°C) or higher.
DO tell your nurse immediately if you feel an itchy rash, shortness of breath, or facial swelling during your IV infusion.
DON’T eat raw meats, unpasteurized dairy, or unwashed fruits and vegetables, as these can carry bacteria that your weakened immune system cannot fight.
DON’T take any new over-the-counter medicines or herbal supplements without asking your oncology team, as they can interact with the chemotherapy.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only and does not constitute medical advice. Treatment protocols, dosages, and side effects vary by individual. Patients should always consult with their primary oncologist or a qualified healthcare professional regarding diagnosis, treatment options, and the management of medical conditions. Do not disregard professional medical advice or delay in seeking it because of something you have read in this material.